NovoCure Limited Ordinary Shares NVCR
$17.04
-1.22%
at last close
Financials (TTM)
- Revenue
- $655.35 million
- Net Income
- $-136,227,000
- Net Margin
- -20.79%
- Return on Equity
- -40.01%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 5.87
- Price / Sales
- 3.05
Over the trailing twelve months, NovoCure Limited Ordinary Shares generated revenue of $655.35 million and net income of $-136,227,000, a net margin of -20.79%.
At the last closing price of $17.04, NVCR trades at 3.05 times sales, with a market capitalization of $2.00 billion.
Key Stats
- Last Close
- $17.04
- Market Cap
- $2.00 billion
- 52-Week Range
- $9.82 – $20.06
- Average Volume
- 1.73 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.